ITMI910303A0 - Derivati della 5-oxo-l- prolina e loro applicazioni farmaceutiche - Google Patents

Derivati della 5-oxo-l- prolina e loro applicazioni farmaceutiche

Info

Publication number
ITMI910303A0
ITMI910303A0 IT91MI303A ITMI910303A ITMI910303A0 IT MI910303 A0 ITMI910303 A0 IT MI910303A0 IT 91MI303 A IT91MI303 A IT 91MI303A IT MI910303 A ITMI910303 A IT MI910303A IT MI910303 A0 ITMI910303 A0 IT MI910303A0
Authority
IT
Italy
Prior art keywords
oxo
pharmaceutical applications
proline derivatives
proline
derivatives
Prior art date
Application number
IT91MI303A
Other languages
English (en)
Inventor
Stefano Poli
Germano Coppi
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to ITMI910303A priority Critical patent/IT1244548B/it
Publication of ITMI910303A0 publication Critical patent/ITMI910303A0/it
Priority to EP19920101347 priority patent/EP0498268A3/en
Priority to DE199292101347T priority patent/DE498268T1/de
Priority to ES92101347T priority patent/ES2051678T1/es
Publication of ITMI910303A1 publication Critical patent/ITMI910303A1/it
Application granted granted Critical
Publication of IT1244548B publication Critical patent/IT1244548B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
ITMI910303A 1991-02-06 1991-02-06 Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche IT1244548B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI910303A IT1244548B (it) 1991-02-06 1991-02-06 Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
EP19920101347 EP0498268A3 (en) 1991-02-06 1992-01-28 5-oxo-l-proline derivatives and pharmaceutical use thereof
DE199292101347T DE498268T1 (de) 1991-02-06 1992-01-28 5-oxo-l-prolinderivate und deren pharmazeutischen herstellungen.
ES92101347T ES2051678T1 (es) 1991-02-06 1992-01-28 Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910303A IT1244548B (it) 1991-02-06 1991-02-06 Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche

Publications (3)

Publication Number Publication Date
ITMI910303A0 true ITMI910303A0 (it) 1991-02-06
ITMI910303A1 ITMI910303A1 (it) 1992-08-06
IT1244548B IT1244548B (it) 1994-07-15

Family

ID=11358454

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910303A IT1244548B (it) 1991-02-06 1991-02-06 Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche

Country Status (4)

Country Link
EP (1) EP0498268A3 (it)
DE (1) DE498268T1 (it)
ES (1) ES2051678T1 (it)
IT (1) IT1244548B (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256178B (it) * 1992-11-30 1995-11-29 Lorenzo Ferrari Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US6197794B1 (en) * 1998-01-08 2001-03-06 Celltech Therapeutics Limited Phenylalanine derivatives
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
WO1999043642A1 (en) 1998-02-26 1999-09-02 Celltech Therapeutics Limited Phenylalanine derivatives as inhibitors of alpha4 integrins
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) * 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
DE10006139A1 (de) * 2000-02-11 2001-08-16 Merck Patent Gmbh Indol-3-yl-Derivate
JP2003531141A (ja) 2000-04-17 2003-10-21 セルテック アール アンド ディ リミテッド エナミン誘導体
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6740654B2 (en) 2000-07-07 2004-05-25 Celltech R & D Limited Squaric acid derivatives
CA2417059A1 (en) 2000-08-02 2002-02-07 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
US20110183925A1 (en) * 2008-09-22 2011-07-28 Nisshin Pharma Inc. Anti-inflammatory peptide
EP3429996A4 (en) 2016-03-16 2020-02-12 H. Lee Moffitt Cancer Center And Research Institute, Inc. SMALL MOLECULES DIRECTED AGAINST CEREBLON TO IMPROVE THE FUNCTION OF T EFFECTOR LYMPHOCYTES
SG11202012464WA (en) 2018-07-11 2021-01-28 H Lee Moffitt Cancer Center And Research Institute Inc Dimeric immuno-modulatory compounds against cereblon-based mechanisms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2202686A1 (en) * 1972-10-13 1974-05-10 Fabre Sa Pierre Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia
IT1019020B (it) * 1973-04-04 1977-11-10 Manetti & Roberts Italo Brit Arginia piroglutamato e procedi mento per prepararlo
DE2423389A1 (de) * 1974-05-14 1975-12-04 Hoechst Ag Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
IT1172391B (it) * 1983-12-23 1987-06-18 Polifarma Spa Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche
DE3689508T2 (de) * 1985-10-14 1994-05-11 Nippon Zoki Pharmaceutical Co Peptide.
IT1202426B (it) * 1987-01-26 1989-02-09 Poli Ind Chimica Spa Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
JPH0699307B2 (ja) * 1987-08-20 1994-12-07 キッセイ薬品工業株式会社 抗痴呆剤
IT1230706B (it) * 1989-02-10 1991-10-29 Poli Ind Chimica Spa Derivati dell'acido 3 piroglutamoil tiazolidin 4 carbossilico e loro proprieta' farmacologiche.
IT1237474B (it) * 1989-10-05 1993-06-07 Polifarma Spa Composti tripeptidici e loro uso farmaceutico come immuno-modulatori

Also Published As

Publication number Publication date
ES2051678T1 (es) 1994-07-01
EP0498268A2 (en) 1992-08-12
IT1244548B (it) 1994-07-15
EP0498268A3 (en) 1993-12-08
ITMI910303A1 (it) 1992-08-06
DE498268T1 (de) 1992-12-17

Similar Documents

Publication Publication Date Title
ITMI910303A1 (it) Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
IT1266582B1 (it) Derivati (di)azacicloesanici e diazacicloeptanici
ITMI920408A1 (it) Derivati benzopiranici e benzotiopiranici
IT8947823A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti
ITMI912237A0 (it) Derivati di geneserina loro preparazione e composizioni farmaceutiche che li contengono
ITTO920719A1 (it) Derivati benzopiranici
IT8948682A0 (it) Derivati della capsaicina, loro preparazione e loro impiego come medicamenti (caso 700-0062)
FI933136A0 (fi) Antiallergiska och antiinflammatoriska n-hydroxiureaderivat
ITMI942026A0 (it) Derivati della colchicina e loro impiego terapeutico
IT9022268A0 (it) Derivati della partricina
ITMI911470A1 (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
IT8822760A0 (it) Ciclodestrinclatrati di derivati della 5-ciano-prostaciclina e loro impiego come medicinali
NO922934D0 (no) Cykloheksan- og tetrahydropyranderivater
ITPD910110A1 (it) Derivati della cumarina.
ITMI932073A1 (it) Derivati di tioalchiltio carbacefalosporina e loro uso come antibiotici
ITMI920884A0 (it) Derivati del flavone
ITMI910359A0 (it) Impiego medicamentoso di derivati diidropiridinici
ITTO920606A0 (it) Derivati di decaidro-8h-isochino/2,1-g/1,6/naftiridina e decaidrobenzo/a/pirrolo/2,3-e/chinolizina
IT1227674B (it) Nuovi derivati fosfonacetici e loro impiego
ITMI932718A0 (it) Derivati del pirrolo e loro impieghi
ITRM920060A0 (it) Xenocollagene e derivati a61
ITMI931729A1 (it) Derivati benzossazinonici e benzotiazinonici e loro uso terapeutico
DK146689D0 (da) Organiske forbindelser og farmaceutiske anvendelser deraf

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19941026